Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III
Europace · 2026
DOI: 10.1093/europace/euag214 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2026. Verfasst von Mashroor Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm SE 141 86, Sweden. Hauptthemen laut MEDLINE: Atrial Fibrillation, Mass Screening, Patient Participation. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart and Lung foundation, CIMED, Vinnova, Swedish Research Council, Region Stockholm.
Abstract (Originalsprache)
Aims
Population-based screening for atrial fibrillation (AF) should be considered in elderly individuals to enable AF detection. However, participation in systematic screening programmes is often suboptimal. STROKESTOP III evaluated whether opportunistic screening could improve participation compared with systematic screening. Methods and results STROKESTOP III is a cluster-randomized trial including individuals aged 75–76 years from 16 primary care centres in Region Värmland, Sweden. Centres were randomized to systematic screening, using mailed invitations, or opportunistic screening, using invitations during visits. In the systematic arm, 1312 individuals were eligible and invited, of whom 607 participated (46.3%). In the opportunistic arm, 1390 individuals attended participating primary care centres and were potentially eligible for invitation. However, 641 individuals (46.1%) were not assessed for eligibility. Among the 749 assessed individuals, 609 were eligible and 374 participated. Participation among invited eligible individuals was significantly higher with opportunistic than systematic screening (374/609, 61.4% vs. 607/1,312, 46.3%; P < 0.005). However, overall reach was lower in the opportunistic arm because of incomplete assessment for invitation (374/1,479, 25.3% vs. 607/1,437, 42.2%; P < 0.005). Participants in the opportunistic arm had a higher cardiovascular risk burden, including more hypertension, diabetes, and a higher CHA2DS2-VASc-score (3.99 vs. 3.60; P < 0.005). Exclusion rates were higher (18.7% vs. 8.7%; P < 0.005), mainly due to previously diagnosed AF and cognitive impairment.
Conclusion
Opportunistic screening increased participation among invited individuals and identified a higher-risk population, but its overall population reach was limited by incomplete eligibility assessment. Combining opportunistic and systematic strategies may optimize reach and participation in AF screening programmes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm SE 141 86, Sweden.
- Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden.
- Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
- Department of Clinical Physiology, Region Värmland, Karlstad, Sweden.
- Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Danderyd, Sweden.
ORCID-Profile: Mashroor Khan, Sofia Skröder, Mårten Rosenqvist, Emma Svennberg
Förderung
- Swedish Heart and Lung foundation, CIMED, Vinnova
- Swedish Research Council
- Region Stockholm
Zitieren
APA
Khan, M., Skröder, S., Ingre, M., Carlstedt, F., Eriksson, A., Star Tenn, J., Rosenqvist, M., & Svennberg, E. (2026). Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III. Europace. https://doi.org/10.1093/europace/euag214
Vancouver
Khan M, Skröder S, Ingre M, Carlstedt F, Eriksson A, Star Tenn J, et al. Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III. Europace. 2026. doi:10.1093/europace/euag214
BibTeX
@article{Khan2026,
author = {Khan, Mashroor and Skröder, Sofia and Ingre, Michael and Carlstedt, Fredrik and Eriksson, Anders and Star Tenn, Johanna and Rosenqvist, Mårten and Svennberg, Emma},
title = {Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag214}
}
EUVIMED